Effect Of Lupeol On Ampk-Mediated Signaling In Gracilis Muscle Of Hfd-Induced Type 2 Diabetic Rats
International Journal of Drug Delivery Technology · 11.05.2026 · 16 (26s)
DOI: 10.25258/ijddt.16.26s.104 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.05.2026. Verfasst von Reddy Prasad und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (t2dm) is characterized by insulin resistance, impaired glucose uptake, oxidative stress, and metabolic dysregulation in skeletal muscle. The camkkβ–ampk–sirt1 signaling axis plays a central role in regulating energy homeostasis, mitochondrial function, and lipid metabolism. Lupeol, a pentacyclic triterpenoid, has demonstrated antidiabetic potential; however, its role in ampk-mediated signaling in skeletal muscle remains unclear.
Objective
This study aimed to investigate the effect of lupeol on ampk-mediated signaling pathways in the gracilis muscle of high-fat diet (hfd)-induced t2dm rats.
Methods
T2dm was induced in rats using a high-fat diet. Animals were divided into four groups: control, hfd-t2dm, hfd-t2dm treated with lupeol, and hfd-t2dm treated with metformin. Oxidative stress markers (lpo, oh•), antioxidant enzymes, and mrna expression of insulin signaling, ampk-related genes, and inflammatory/lipogenic markers were analyzed.
Results
Hfd-induced diabetic rats exhibited increased oxidative stress, reduced antioxidant defenses, impaired insulin signaling, and downregulation of ampk-associated genes. Lupeol treatment significantly decreased lpo and oh• levels while restoring sod, cat, and gsh levels. It upregulated insulin signaling genes (ir, irs-1, akt, glut-4), indicating improved glucose uptake. Furthermore, lupeol enhanced the expression of camkkβ, cpt-1, ppar-γ, and sirt1, suggesting activation of the ampk pathway and improved mitochondrial function. Additionally, lupeol reduced the expression of srebp-1c and tnf-α, indicating suppression of lipogenesis and inflammation. Metformin showed slightly greater effects but with comparable trends.
Conclusion
Lupeol ameliorates skeletal muscle insulin resistance in hfd-induced t2dm by reducing oxidative stress, restoring antioxidant capacity, improving insulin signaling, activating the camkkβ–ampk–sirt1 axis, and suppressing lipogenesis and inflammation. These findings highlight lupeol as a promising multi-targeted therapeutic agent for the management of t2dm
Zitieren
APA
Prasad, R., Kumar, D. R. P., Jayaraman, T., Rajagopal, P., Janaki, C. S., Murali, R., & Jayaraman, S. (2026). Effect Of Lupeol On Ampk-Mediated Signaling In Gracilis Muscle Of Hfd-Induced Type 2 Diabetic Rats. International Journal of Drug Delivery Technology, 16(26s). https://doi.org/10.25258/ijddt.16.26s.104
Vancouver
Prasad R, Kumar DRP, Jayaraman T, Rajagopal P, Janaki CS, Murali R, et al. Effect Of Lupeol On Ampk-Mediated Signaling In Gracilis Muscle Of Hfd-Induced Type 2 Diabetic Rats. International Journal of Drug Delivery Technology. 2026;16(26s). doi:10.25258/ijddt.16.26s.104
BibTeX
@article{Prasad2026,
author = {Prasad, Reddy and Kumar, Doni R Praveen and Jayaraman, Thirunavukkarasu and Rajagopal, Ponnulakshmi and Janaki, C. S. and Murali, Ramya and Jayaraman, Selvaraj},
title = {Effect Of Lupeol On Ampk-Mediated Signaling In Gracilis Muscle Of Hfd-Induced Type 2 Diabetic Rats},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {26s},
doi = {10.25258/ijddt.16.26s.104}
}
EUVIMED